Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2024-04-15 Report Publication Anno…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2024
Report Publication Announcement Classification · 1% confidence The document is titled "Evotec SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is a 'Preliminary announcement of the publication of financial reports' and lists future disclosure dates for the 'Annual financial report of the group' and the 'Financial report of the group (half-year/Q2)'. Since the document itself is an announcement about when other reports will be released, and not the reports themselves, it fits the definition of a Report Publication Announcement (RPA). The document length (2393 chars) is short, supporting the RPA classification over the full report classification (like 10-K or IR).
2024-04-15 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections labeled 'Notification of Major Holdings' which track changes in voting rights percentages (e.g., New: 12.01 %, Previous: 10.11 %) held by a shareholder (T. Rowe Price Group, Inc.) in the issuer (Evotec SE). This directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS, the specific content is about a major holding change, making MRQ more precise than the general RNS fallback.
2024-04-05 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a legal entity (BlackRock, Inc.) in Evotec SE, referencing specific German securities law articles (WpHG). This directly corresponds to the definition of a notification regarding changes in significant share ownership thresholds, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal disclosure of holding percentages crossing thresholds, which is the core function of a major shareholding notification.
2024-03-20 English
Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic
Regulatory Filings Classification · 1% confidence The document is a news release dated March 6, 2024, announcing a strategic agreement between Evotec SE and Claris Ventures to streamline drug development programs. It contains standard corporate news elements, including quotes from management, details about the collaboration, and boilerplate information about both companies. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement distributed via a news service (EQS-News) that doesn't fit into the highly specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings.
2024-03-06 English
Evotec SE: Dr. Cord Dohrmann, sell
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details a disposal transaction by Dr. Cord Dohrmann, a Member of the managing body of Evotec SE, including the price, volume, and date of the transaction. This directly matches the definition for Director's Dealing (DIRS).
2024-02-12 English
Just Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Regulatory Filings Classification · 1% confidence The document is a press release dated February 7, 2024, disseminated via EQS News. It announces a business development: Evotec Biologics expanding a development and manufacturing agreement with ABL regarding HIV antibodies. This type of announcement, detailing a specific business contract, partnership expansion, or operational update that is not a mandatory periodic financial filing (like 10-K or IR) or a specific event announcement (like AGM or Dividend), typically falls under general corporate news or regulatory filings. Since it is a specific, material business update released to the public via a news service, and it doesn't fit the definitions for ER (Earnings Release), CAP (Financing Update), or TAR (M&A), the most appropriate general category for a significant, non-periodic corporate announcement that isn't a standard financial report is Regulatory Filings (RNS), which serves as a broad category for material news releases not covered elsewhere. It is not an announcement of a report publication (RPA) because it contains the substantive news itself, not just a notice that a report is available.
2024-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.